Optimal Timing From Myocardial Infarction to Coronary Artery Bypass Grafting on Hospital Mortality

Elizabeth L Nichols1, Jock N McCullough2, Cathy S Ross1

  • 1The Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth, Lebanon.

Insights

Delaying coronary artery bypass grafting (CABG) after myocardial infarction (MI) for 1-7 days shows similar in-hospital death rates. However, performing CABG in less than 1 day post-MI is associated with higher mortality.

Area of Science:

  • Cardiovascular Surgery
  • Interventional Cardiology
  • Clinical Outcomes Research

Background:

  • The optimal timing for coronary artery bypass grafting (CABG) after myocardial infarction (MI) remains debated.
  • Uncertainty exists regarding whether delaying CABG post-MI improves outcomes or unnecessarily consumes healthcare resources.

Purpose of the Study:

  • To investigate the association between the time interval from myocardial infarction (MI) to coronary artery bypass grafting (CABG) and in-hospital mortality.
  • To determine if early CABG after MI impacts patient survival.

Main Methods:

  • Analysis of 3,060 isolated CABG patients with prior MI from the Northern New England Cardiovascular Disease Study Group registry (2008-2014).
  • Comparison of in-hospital death rates based on MI-to-CABG timing: <1 day, 1-2 days, 3-7 days, and 8-21 days.
  • Logistic regression was used to adjust for patient characteristics.

Main Results:

  • In-hospital mortality was higher for CABG performed <1 day after MI (adjusted 5.4%) compared to other intervals.
  • Adjusted in-hospital mortality rates were similar for CABG performed 1-2 days (1.8%), 3-7 days (1.7%), and 8-21 days (2.3%) after MI.
  • Predicted mortality was similar for 1-day, 1-2 day, and 3-7 day intervals, but higher for the 8-21 day interval.

Conclusions:

  • Performing CABG 1-2 days or 3-7 days after MI is associated with similar mortality rates, suggesting potential for reducing the MI-to-CABG interval.
  • Operating within 1 day of MI was linked to a higher in-hospital mortality rate.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
386
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
374
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.4K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.1K